Suscribirse

Does lymph node ratio affect prognosis in gastroesophageal cancer? - 14/08/15

Doi : 10.1016/j.amjsurg.2014.12.042 
Marcovalerio Melis, M.D., F.A.C.S. a, , Antonio Masi, M.D. a, Antonio Pinna, M.D. a, b, Steven Cohen, D.O., F.A.C.S. a, Ioannis Hatzaras, M.D. a, Russell Berman, M.D., F.A.C.S. a, Leon H. Pachter, M.D., F.A.C.S. a, Elliot Newman, M.D., F.A.C.S. a
a Department of Surgery, NYU School of Medicine, 550 First Avenue, NBV 15N1, New York, NY 10016, USA 
b Department of General Surgery, Clinica Chirurgica, University of Sassari, Viale San Pietro 43/B, 07100 Sassari, Italy 

Corresponding author. Tel.: +1-212-686-7500; fax: +1-212-951-3373.

Abstract

Background

Increasing evidence suggests that the ratio of number of nodes harboring metastatic cancer to the total number of lymph nodes examined (lymph node ratio, LNR) may affect survival after esophagogastric resection for cancer. We analyzed the impact of LNR in overall survival in patients undergoing esophagogastric resection for cancer.

Methods

Patients who underwent gastroesophageal resection for cancer (1998 to 2008) were categorized into 4 groups according to their LNR: 113 patients had negative nodes (N0), 86 LNR less than .3, 40 LNR .31 to .6, and 47 LNR greater than .6. Study endpoint was overall median survival.

Results

Higher LNR was associated (P < .001) with more advanced stage and adverse pathologic features (eg, grading, venous/perineural invasion). Multivariate analysis demonstrated that LNR is an independent predictor of survival.

Conclusion

In our experience, LNR correlates with adverse pathologic features and is a negative prognostic factor in patients undergoing radical resection for gastroesophageal cancer.

El texto completo de este artículo está disponible en PDF.

Highlights

Current N staging system for gastroesophageal cancers rely on absolute number of positive lymph nodes, which is determined not only by tumor biology but also by the extent of lymph node dissection. For example, a gastric cancer classified as N1 after limited lymph node dissection may have been classified as N2 or N3 if a more extensive lymphadenectomy was performed, a phenomenon called “stage migration.” Therefore, N stage may be influenced by the surgeon’s attitude toward the lymph node dissection, especially in Western countries where D1 lymph node dissection remains an accepted treatment modality.
Use of LNR (ratio between the absolute number of metastatic lymph node and the total number of lymph nodes harvested at the time of gastric resection) instead of absolute number of positive lymph nodes may minimize stage migration.
Use of LNR has not been extensively validated in a US population. Our study confirms that LNR can be effectively used as a prognostic indicator in a US population of patients undergoing resection of gastroesophageal cancer. Furthermore, to our knowledge, our study is the first to report specifically on relationship of LNR with status of resection margins.

El texto completo de este artículo está disponible en PDF.

Keywords : Lymph node ratio, Gastroesophageal cancer, Prognosis


Esquema


 The authors report no proprietary or commercial interest in any product mentioned or concept discussed in this article.
 The authors declare no conflicts of interest.


© 2015  Publicado por Elsevier Masson SAS.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 210 - N° 3

P. 443-450 - septembre 2015 Regresar al número
Artículo precedente Artículo precedente
  • Effect of the number of lymph nodes harvested on the long-term survival of gastric cancer patients according to tumor stage and location: a 12-year study of 1,637 cases
  • Zhanlong Shen, Yingjiang Ye, Qiwei Xie, Bin Liang, Kewei Jiang, Shan Wang
| Artículo siguiente Artículo siguiente
  • The economic and logistical burden of care for severe work-related injuries in a level 1 tertiary care trauma referral center
  • Connal Robertson-More, Bryan J. Wells, Duncan Nickerson, Andrew W. Kirkpatrick, Chad G. Ball

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

@@150455@@ Voir plus

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2026 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.